Direkt zum Inhalt
Merck

Fortfahren mit

1A03750

USP

DABIGATRAN HEPTANE-2-YL ANALOG

Pharmaceutical Analytical Impurity (PAI)

Synonym(e):

Dabigatran Heptane-2-yl Analog, (ethyl 3-(2-(((4-(N-((heptan-2-yloxy)carbonyl)carbamimidoyl)phenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate)

Anmelden zur Ansicht der Organisations- und Vertragspreise.

Größe auswählen

Ansicht ändern
Größe/SKUVerfügbarkeitPreis

Über diesen Artikel

Empirische Formel (Hill-System):
C35H43N7O5
CAS-Nummer:
Molekulargewicht:
641.76
MDL number:
NACRES:
NA.24
UNSPSC Code:
41116107
eCl@ss:
25140904
Preise und Verfügbarkeit sind derzeit nicht verfügbar.
Technischer Dienst
Benötigen Sie Hilfe? Unser Team von erfahrenen Wissenschaftlern ist für Sie da.
Unterstützung erhalten


grade

pharmaceutical analytical impurity (PAI)

agency

USP

API family

dabigatran

manufacturer/tradename

USP

application(s)

pharmaceutical
pharmaceutical
pharmaceutical small molecule

format

neat

storage temp.

-10 to -25°C

General description

Find answers to frequently asked questions on USP products in USP FAQs.
Dabigatran Heptane-2-yl Analog is a USP Pharmaceutical Analytical Impurity (PAI).


USP PAI are a product line of impurities suitable for research and analytical purposes, which help to ensure the quality and safety of medicines.


Associated Drug Substance: Dabigatran Etexilate Mesylate


Therapeutic Area: Anticoagulants & Antiplatelets

Application

Dabigatran Heptane-2-yl Analog (USP PAI) is intended for use in analytical testing to detect, identify, and measure pharmaceutical impurities.

Features and Benefits

USP PAI advance your early analytical R&D and process development. PAI can be used in the following applications:
1. Conduct analytical tests during early formulation feasibility studies.
2. Determine degradation impurities produced during stress studies.
3. Develop, validate, and transfer analytical methods.
4. Perform spiking studies during process R&D to demonstrate depletion upon recrystallization.
5. Record retention times and/or spectra
6. Determine relative response factors.
7. Identify unknown impurities that formed during ICH stability conditions.
8. Identify impurities that are present in the Reference Listed Drug
9. Test for and profile impurities not listed in drug substance and drug product monographs.

Analysis Note

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.  

Other Notes

Sales restrictions may apply.
USP issued SDS can be found here

Ähnliche Artikel vergleichen

Vollständigen Vergleich anzeigen

Unterschiede anzeigen

1 of 1

Dieser Artikel
PHR84251A037401162262
description

Pharmaceutical Analytical Impurity (PAI)

description

pkg of 30 mg, certified reference material, pharmaceutical secondary standard

description

Pharmaceutical Analytical Impurity (PAI)

description

United States Pharmacopeia (USP) Reference Standard

grade

pharmaceutical analytical impurity (PAI)

grade

certified reference material, pharmaceutical secondary standard

grade

pharmaceutical analytical impurity (PAI)

grade

pharmaceutical primary standard

manufacturer/tradename

USP

manufacturer/tradename

-

manufacturer/tradename

USP

manufacturer/tradename

USP

format

neat

format

neat

format

neat

format

neat

application(s)

pharmaceutical small molecule

application(s)

pharmaceutical

application(s)

pharmaceutical small molecule

application(s)

pharmaceutical

agency

USP

agency

(Not traceable to any primary pharmacopeia standard)

agency

USP

agency

USP

storage temp.

-10 to -25°C

storage temp.

-10 to -25°C

storage temp.

2-8°C

storage temp.

2-8°C


Lagerklasse

11 - Combustible Solids

Flammpunkt (°F)

Not applicable

Flammpunkt (°C)

Not applicable



Hier finden Sie alle aktuellen Versionen:

Analysenzertifikate (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Dokumente section.

Wenn Sie Hilfe benötigen, wenden Sie sich bitte an Kundensupport

Besitzen Sie dieses Produkt bereits?

In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.

Die Dokumentenbibliothek aufrufen